A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in billary and pancreatic malignancies

被引：0
|
作者：
Leong, S. [1 ]
Obryant, C. L. [1 ]
Messersmith, W. A. [1 ]
Diab, S. [1 ]
Kane, M. A. [1 ]
Nallapreddy, S. [1 ]
Weekes, C. [1 ]
Spratlin, J. [1 ]
Call, J. [1 ]
Eckhardt, S. G. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72336-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] A phase I study of gemcitabine, capecitabine, and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies
    Nallapareddy, S.
    Eckhardt, S. G.
    O'Bryant, C. L.
    Eppers, S.
    Diab, S.
    Kane, M. A.
    Weekes, C. D.
    Spratlin, J. L.
    Messersmith, W. A.
    Leong, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Kessler, Elizabeth R.
    Eckhardt, S. Gail
    Pitts, Todd M.
    Bradshaw-Pierce, Erica L.
    O'byrant, Cindy L.
    Messersmith, Wells A.
    Nallapreddy, Sujatha
    Weekes, Colin
    Spratlin, Jennifer
    Lieu, Christopher H.
    Kane, Madeleine A.
    Eppers, Sarah
    Freas, Elizabeth
    Leong, Stephen
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 176 - 183
  • [3] Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
    Elizabeth R. Kessler
    S. Gail Eckhardt
    Todd M. Pitts
    Erica L. Bradshaw-Pierce
    Cindy L. O’byrant
    Wells A. Messersmith
    Sujatha Nallapreddy
    Colin Weekes
    Jennifer Spratlin
    Christopher H. Lieu
    Madeleine A. Kane
    Sarah Eppers
    Elizabeth Freas
    Stephen Leong
    Investigational New Drugs, 2016, 34 : 176 - 183
  • [4] Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer
    Siu, LL
    Awada, A
    Takimoto, CH
    Piccart, M
    Schwartz, B
    Giannaris, T
    Lathia, C
    Petrenciuc, O
    Moore, MJ
    CLINICAL CANCER RESEARCH, 2006, 12 (01) : 144 - 151
  • [5] Phase I study of fixed-dose rate (FDR) gemcitabine with capecitabine in advanced solid malignancies
    Attia, S.
    Eickhoff, J.
    Holen, K. D.
    Bailey, H.
    Alberti, D.
    Wilding, G.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [7] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [8] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
    Tan, B. R.
    Brenner, W. S.
    Picus, J.
    Marsh, S.
    Gao, F.
    Fournier, C.
    Fracasso, P. M.
    James, J.
    Yen-Revollo, J. L.
    Mcleod, H. L.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1742 - 1748
  • [10] Biweekly oxaliplatin with gemcitabine and capecitabine in advanced gastrointestinal malignancies: A phase I study
    Tan, B. R.
    Brenner, W. S.
    Picus, J.
    Suresh, R.
    Sorcher, S.
    James, J. S.
    Fournier, C.
    Mcleod, H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345